Revenue Growth Driven by Core Business Expansion
Total revenue grew 5.8% YoY to $3.54B in Q1 FY2026, up from $3.35B in the prior-year period, indicating broad-based demand across LH's laboratory and diagnostic services segments.
LABCORP HOLDINGS INC. is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: LH (Labcorp) delivered strong Q1 FY2026 results with revenue up 5.8% YoY to $3.54B, net income surging 30.5% to $277.8M, and operating cash flow jumping 935% to $191.5M, reflecting solid operational leverage and disciplined cost management.
Drawn from management commentary in the Q1 2026 10-Q:
Total revenue grew 5.8% YoY to $3.54B in Q1 FY2026, up from $3.35B in the prior-year period, indicating broad-based demand across LH's laboratory and diagnostic services segments.
Operating income rose 16.8% YoY to $380.8M while SG&A expenses grew only 0.9% to $551.0M, demonstrating strong operating leverage as revenue growth significantly outpaced overhead cost increases. Operating margin expanded approximately 100 basis points to 10.8%.
Net income surged 30.5% YoY to $277.8M, with diluted EPS rising 32.9% to $3.35 from $2.52, reflecting both improved profitability and the benefit of share repurchases totaling $98.0M in the quarter (no buybacks in prior-year period).
Revenue
$3.54B
++5.75% YoY
EPS (Basic)
$3.37
++32.68% YoY
Gross Margin
28.7%
++0.32% YoY
Operating Income
$380.8M
++16.81% YoY
Add LH to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.